Metizoline
- Level
- Commodity
- Parent
- 51392200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51392206This classification denotes an imidazole with the molecular formula C13H14N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z27L8N105U, chemically known as 1h-imidazole, 4,5-dihydro-2-((2-methylbenzo(b)thien-3-yl)methyl)- but generally known as metizoline, which bears US NIH Compound Identifier 28688. European Medicines Agency schedules Metizoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08898MIG. World Health Organization schedules metizoline in its Anatomical Therapeutic Chemical (ATC) Classification. METIZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metizoline under HS 29349990 and SITC 51579. As of Q4 2014, METIZOLINE remains the US FDA Preferred Term for this commodity. Metizoline bears US NLM identifiers UMLS ID C0604284 and NCI Concept Code C99577. SMILES: S1C(C(CC2=NCCN2)C2C1CCCC2)C.
Same parent
Under 51392200 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.